Connect with us

Technology

Smart Wearable Healthcare Devices Market size is set to grow by USD 24.22 billion from 2024-2028, Increasing focus on patient engagement boost the market, Technavio

Published

on

NEW YORK, July 31, 2024 /PRNewswire/ — The global smart wearable healthcare devices market size is estimated to grow by USD 24.22 billionn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.51% during the forecast period. Increasing focus on patient engagement is driving market growth, with a trend towards increasing adoption of self-monitoring of vital organs. However, concerns associated with data privacy poses a challenge. Key market players include Alphabet Inc., Apple Inc., Biobeat Technologies Ltd., BioIntelliSense Inc., Biotricity Inc., Boston Scientific Corp., Contec Medical Systems Co. Ltd., Cyrcadia Asia Ltd., Dexcom Inc., Garmin Ltd., Huawei Technologies Co. Ltd., iRhythm Technologies Inc., Koninklijke Philips N.V., Masimo Corp., Nokia Corp., OMRON Corp., Polar Electro Oy, Samsung Electronics Co. Ltd., ten3T Healthcare, and VitalConnect Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Smart Wearable Healthcare Devices Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 15.51%

Market growth 2024-2028

USD 24.22 billion

Market structure

Fragmented

YoY growth 2022-2023 (%)

13.65

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 34%

Key countries

US, Canada, Germany, UK, and China

Key companies profiled

Alphabet Inc., Apple Inc., Biobeat Technologies Ltd., BioIntelliSense Inc., Biotricity Inc., Boston Scientific Corp., Contec Medical Systems Co. Ltd., Cyrcadia Asia Ltd., Dexcom Inc., Garmin Ltd., Huawei Technologies Co. Ltd., iRhythm Technologies Inc., Koninklijke Philips N.V., Masimo Corp., Nokia Corp., OMRON Corp., Polar Electro Oy, Samsung Electronics Co. Ltd., ten3T Healthcare, and VitalConnect Inc.

Market Driver

Smart wearable healthcare devices, including wearable gadgets and mobile apps, are gaining popularity for self-tracking and self-monitoring applications. These devices collect, process, and display personal health records, enabling users to monitor and manage their vital signs. Five primary vital signs, including temperature, pulse, respiration, blood pressure, and pain, are regularly monitored. Self-monitoring is crucial for maintaining overall health and well-being. Hospitals use these devices to monitor patients’ progress during treatment, allowing for prompt detection of delayed recovery or adverse events. Wireless transmission of patient data to remote monitoring centers enables patients to move freely while under observation. Recording vital parameters in medical information systems for later analysis by healthcare professionals is another significant trend driving the smart wearable healthcare market. 

The Smart Wearable Healthcare Devices market is experiencing significant growth, particularly in the areas of Fitness, Diabetes, and Cardiovascular Diseases. With the IDF Diabetes Atlas reporting over 537 million people living with diabetes worldwide, there’s a high demand for wearable devices that can monitor and manage Type 2 diabetes. Similarly, the increasing prevalence of Cardiovascular Diseases (CVDs), including Hypertension and High Cholesterol, is driving innovation in this space. However, challenges such as privacy and security concerns, including unauthorized access to personal health information by cyber criminals, remain. Ground-breaking wearable devices like the BioButton multiparameter wearable are addressing these concerns with advanced Artificial Intelligence (AI) and Machine Learning (ML) capabilities. Reimbursement policies and per capita expenditure are also key factors influencing market growth. The aging population, investments and grants, and wireless connectivity are also fueling the development of smartphone-based healthcare devices and home healthcare solutions. Fitness tracking capabilities, such as those offered by smartwatches and wearable activity monitors, are popular among consumers. Data standardization, clinical trial platforms, and data accuracy are essential for ensuring the effectiveness and reliability of these devices. Fraud prevention and high-speed 5G networks are also critical for secure medical imagery transmission. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

Smart wearable healthcare devices offer valuable health insights but pose privacy and security concerns due to the sensitive data they store. Their small size increases the risk of loss or misplacement. Location-based services, such as Google Glass and Foursquare, require sharing user locations, raising privacy issues. Security breaches are a potential threat, as data leakage can lead to serious consequences. Network operators have access to location data, raising concerns about privacy and potential misuse. These factors may hinder the growth of the global smart wearable healthcare devices market during the forecast period.The wearable healthcare device market is experiencing significant growth, with fitness trackers leading the charge. These devices monitor activities like walking, running, swimming, and cycling, providing valuable data on pace, distance, and elevation. Wearable ECG monitors offer early detection and diagnosis of chronic diseases through electrocardiograms. Medical efficiency is improved with real-time health parameter tracking of blood oxygen levels, body temperature, and sleep patterns. Wearable gadgets for training and compensation during sporting activities are driving the mobile healthcare revolution. National agencies and EU member states are implementing regulations for these devices, impacting purchasing power and disposable income. Blood Glucose Meters, Blood Pressure Monitors, Heart Detectors, and Pulse Monitors are also popular. E-commerce platforms facilitate sales of wearable healthcare devices and electronic gadgets. Sensor technologies and preventive healthcare are key trends. Bluetooth connectivity enables data sharing with connected technological devices for comprehensive health management.

For more insights on driver and challenges – Request a sample report!

Segment Overview

This smart wearable healthcare devices market report extensively covers market segmentation by

Product1.1 Fitness band1.2 Smart watches1.3 Smart glassesDistribution Channel2.1 Online2.2 OfflineGeography3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Fitness band- Fitness bands are wearable devices worn on the wrist that monitor and record a user’s physical activity, including steps taken, distance covered, calories burned, and sleep patterns. These devices interact with a mobile application via Bluetooth to configure settings and access data. In 2021, vendors such as Redmi launched new models, like the Smart Band Pro, featuring larger displays, longer battery life, and enhanced water resistance. These advancements contribute to the growth of the global smart wearable healthcare devices market by enabling users to better track their health and fitness goals. Fitness bands provide valuable insights, encouraging healthier habits through self-monitoring, increased exercise, and improved sleep quality. With continuous innovation, the market for these devices is expected to expand significantly during the forecast period.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

The Smart Wearable Healthcare Devices market is experiencing rapid growth due to the increasing adoption of electronic gadgets for health management. These devices, including smartphone-based healthcare tools, offer wireless connectivity for real-time health parameter monitoring and lifestyle management. Home healthcare is a significant sector benefiting from wearable devices, enabling holistic evaluation of health parameters for preventive healthcare. Fitness monitoring is a popular application, with wearables helping individuals manage their fitness levels and track progress towards health goals. Diseases such as diabetes and cardiovascular disease can also be managed effectively using these devices. E-commerce and distribution channels have simplified access to these devices, making them an affordable and convenient option for consumers seeking to improve their health and wellbeing. Sensor technologies continue to advance, enhancing the capabilities of wearable healthcare devices and driving market growth.

Market Research Overview

Smart wearable healthcare devices refer to technology-enabled accessories that monitor and manage various health-related issues, including fitness tracking, body temperature, heart rate, blood pressure, sleep statistics, and remote patient monitoring. These devices leverage wireless connectivity to transmit real-time data to healthcare providers, insurers, and consumers. Lifestyle management is a significant application of wearable healthcare devices, with features like fitness tracking capabilities, smartwatches, wearable activity monitors, and smartphone apps. Home healthcare applications are also gaining popularity, with devices such as patches, trackers, and smart clothing. High-speed 5G networks enable advanced applications like medical imagery, augmented reality (AR), and virtual reality (VR) in wearable healthcare devices. Data standardization, consumer privacy, cybersecurity attacks, data accuracy, fraud prevention, and battery life are crucial considerations in this market. Wearable healthcare devices include smartphones, implants, accessories, clothing, and body trackers and monitors. They cater to patients, doctors, nurses, clinical personnel, hospitals, and home healthcare settings, offering a holistic evaluation of health-related issues. Wearable technology companies like Fitbit, wearable monitors, and wristbands with sensors are transforming the healthcare industry by enabling physical activity tracking, step progress, notifications, short messages, phone calls, and exercise-related features for walking, running, swimming, and bicycling.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductFitness BandSmart WatchesSmart GlassesDistribution ChannelOnlineOfflineGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/smart-wearable-healthcare-devices-market-size-is-set-to-grow-by-usd-24-22-billion-from-2024-2028–increasing-focus-on-patient-engagement-boost-the-market-technavio-302209925.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets

Published

on

By

Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI Drug Discovery Platform

TOKYO, April 14, 2025 /PRNewswire/ — PRISM BioLab, Co. Ltd. (“PRISM BioLab”), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a drug discovery collaboration with Elix, Inc. (“Elix”), effective April 1, 2025.

This partnership will accelerate research on these challenging molecular targets by combining PRISM BioLab’s proprietary peptide mimetic technology for controlling protein-protein interactions with Elix’s cutting-edge AI drug discovery platform.

In drug discovery, generating a clinical candidate molecule typically takes long time and requires synthesis of hundreds to thousands of compounds, making research and development efficiency a critical challenge. Through this partnership, PRISM BioLab’s proprietary small molecule peptide-mimetic PepMetics® technology will be integrated with Elix’s AI drug discovery platform “Elix Discovery™.” This collaboration will expand the AI search range to include previously unconsidered small molecules, enabling efficient identification of promising compounds for traditionally difficult targets and accelerating the creation of breakthrough drug candidates. By leveraging both companies’ AI capabilities and medicinal chemistry expertise, the partnership aims to reduce time and costs and improve success rate of drug discovery, ultimately delivering innovative treatments for unmet medical needs.

Comments from Executives

Elix co-founder and CEO Shinya Yuki, Ph.D.:

In our previous pilot project with PRISM BioLab, we achieved breakthrough results by creating novel compound candidates with an efficiency that would be unimaginable using conventional approaches. This success clearly demonstrated that the combination of our companies’ technologies and expertise holds tremendous potential in drug discovery. I am genuinely looking forward to this business partnership, where we can leverage our complementary strengths to pursue outcomes that neither company could achieve alone.

PRISM BioLab CEO Dai Takehara:

As we challenge ourselves to ‘create new areas of drug discovery’ with peptide-mimetic small molecules, AI utilization is essential. We expect our efforts to be significantly accelerated through collaboration with Elix, whose mission is to ‘rethink drug discovery.’ Our pilot project has already demonstrated the synergistic effect of our technologies and team collaboration, and we will continue to pursue the early creation of groundbreaking new drugs together.

PRISM BioLab CTO Tatsuya Toma Ph.D.:

Improving drug discovery efficiency is an eternal challenge. Delivering better medicines to patients and healthcare professionals as quickly as possible requires innovation. Our PepMetics® technology has characteristics that are highly compatible with AI applications. Elix is not only a professional in AI and machine learning but also expanding their knowledge and understanding of drug discovery while maintaining a flexible corporate culture. They have shown great interest in PepMetics® features, and I believe we can advance comprehensive drug discovery research together, leveraging PepMetics® characteristics to accelerate the process.

About Elix

Elix is an AI drug discovery company with the mission of “Rethinking drug discovery”. Through their flagship software platform, Elix Discovery™, and collaborative consulting engagements, they work with leading pharmaceutical companies and biotech startups to reduce the enormous costs and time associated with drug discovery, while improving the rate of successful outcomes. They achieve these goals via their company’s unique blend of AI engineering and medicinal chemistry expertise that allows them to stay at the forefront of development in both fields, and offer the solutions of tomorrow to the problems of today.

https://www.elix-inc.com/ 

About PRISM BioLab

PRISM BioLab is a discovery and development biotechnology company utilizing proprietary PepMetics® technology to discover orally available small molecule inhibitors of protein-protein interaction (PPI) targets and transform lives of patients suffering from cancer, autoimmune, fibrosis and other diseases. PepMetics® are a unique class of small molecules that mimic three-dimensional structures of alpha-helix and beta-turn, the peptide structures commonly found in intracellular PPI interphases and receptor-ligand interactions. By combining proprietary chemistry, know-how around PPI targets and AI-supported design, PepMetics® technology can deliver inhibitors of challenging PPI targets. The technology holds promise to expand the field of drug discovery by turning previously undruggable PPIs into targets readily druggable with small molecules and by generating oral small molecule alternatives for injectable biologics.

PRISM BioLab is collaborating on new PPI targets with global and Japanese pharmaceutical companies. PepMetics® targeting CBP/beta-catenin PPIs licensed to Eisai Co., Ltd. and Ohara Pharmaceutical Co., Ltd. are in clinical development for cancer and liver disease, respectively.

www.prismbiolab.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/prism-biolab-and-elix-join-forces-to-accelerate-ai-driven-drug-discovery-for-protein-protein-interaction-targets-302426497.html

SOURCE PRISM BioLab Co., Ltd.

Continue Reading

Technology

RIAD Corp. reveals AI-powered hotel group booking platform Ria at ITB Berlin 2025

Published

on

By

BERLIN, April 14, 2025 /PRNewswire/ — Riad Corporation, a leading AI-powered travel technology company, successfully launched its flagship product, RIA 1.0, at ITB Berlin 2025, one of the world’s largest travel trade shows. The company attracted over 300 visitors to its booth and secured 150 enterprise client sign-ups during the three-day event, marking a major milestone for its global expansion.

RIA 1.0 is an advanced AI platform that fully automates group hotel reservations, tailored for travel agencies and corporate clients handling complex requirements. Unlike traditional systems, RIA enables both direct bookings and customized group requests, processed entirely by AI without manual work. The platform simplifies large-scale, multi-hotel bookings — tasks that usually take days — completing them in minutes.

During ITB Berlin, Riad Corporation presented live demonstrations showing how RIA’s AI engine handles diverse, high-volume booking scenarios. Attendees praised its intuitive interface, seamless integration, and real-time responses to specific client needs, including corporate events, MICE bookings, and incentive groups.

Mike Lee, CEO of Riad Corporation, commented, “Meeting so many global partners at ITB Berlin was truly meaningful, and we are proud to showcase our technology to the world,” adding, “We will continue to focus on R&D to deliver stronger innovations and achieve greater success globally.”

In addition, Riad Corporation announced plans to launch AI-based group flight booking services later this year, transforming RIA into a comprehensive group travel platform covering both hotels and flights.

RIA has already gained momentum in Southeast Asia, with over 800 enterprise clients, and aims to reach 2,000 clients by the end of 2025.

Riad Corporation’s strong debut at ITB Berlin reflects rising demand for AI-driven solutions in travel. As group travel grows more complex, RIA 1.0 is positioned to lead the market with unmatched speed, accuracy, and automation.

For more information about Riad’s solution RIA, visit ‘www.ria-travel.com‘.

Photo – https://mma.prnewswire.com/media/2646943/ria.jpg
Logo – https://mma.prnewswire.com/media/2646944/RIAD_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/riad-corp-reveals-ai-powered-hotel-group-booking-platform-ria-at-itb-berlin-2025-302424402.html

Continue Reading

Technology

GameChange Solar Closes FY 25 in India with Strong Order Momentum

Published

on

By

Order bookings exceed 7 GW in FY25Total India projects (commissioned as well as under installation) cross 13 GWOver 20 GW local manufacturing capacity for key components

BENGALURU, India , April 14, 2025 /PRNewswire/ — GameChange Solar, a leading global supplier of solar tracker and fixed-tilt racking technology, has closed FY 25 on a strong note in the Indian market, with total order bookings of 7 GW. Of this, nearly 2 GW of tracker orders were signed in Q4 FY 25, marking a robust end to the financial year.

With this milestone, GameChange Solar’s total projects in India (commissioned as well as under installation) have now exceeded 13 GW, reinforcing its position as a trusted technology partner in the country’s growing utility-scale solar segment. A significant portion of these new orders represents repeat business from clients, reflecting GameChange Solar’s proven performance, consistent execution, and customer-first approach.

To support this growth, the company’s local manufacturing capacity for key components has surpassed 20 GW annually, enabling faster deliveries and stronger alignment with project timelines.

India continues to be one of the most exciting and dynamic solar markets globally, and this strong finish to FY 25 reflects the valued relationships we’ve built with our customers and the reliability of our Genius Tracker™ systems,” said Vikas Bansal, President – International at GameChange Solar. “What’s particularly encouraging is the consistency of demand across states, developer profiles, and project sizes – from first-time engagements to repeat orders. It shows that the market isn’t just growing, it’s maturing, and there’s a clear preference for scalable, execution-focused partners who can deliver at speed.”

GameChange Solar’s Genius Tracker™ solutions are engineered for high-wind, high-heat environments – combining speed, structural durability, and precision tracking to maximize output and reduce project timelines. Their versatility makes them ideally suited for India’s diverse terrains and aggressive commissioning schedules.

For more information about GameChange Solar and its solar tracking solutions, visit www.gamechangesolar.com

About GameChange Solar

GameChange is the second largest global provider of solar tracker solutions used in utility-scale and ground-mounted distributed generation solar projects around the world. We have delivered over 43 GW of solar tracker and fixed tilt systems that combine fast installation, bankable quality, and unbeatable value through superior engineering, innovative design, and high-volume manufacturing. Our products enable solar panels at power plants to follow the sun’s movement across the sky and optimize plant performance while protecting the array from damaging weather conditions.

Media Contact

Nisha Wadhwani

Lead – Marketing, GameChange Solar

nisha.wadhwani@gamechangesolar.com

Logo – https://mma.prnewswire.com/media/1592922/GameChange_Solar_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/gamechange-solar-closes-fy-25-in-india-with-strong-order-momentum-302426929.html

Continue Reading

Trending